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The third quarterly report required by the contract under which this work
is being carried out covers the months of April, Ifeiy and June 1953 and includes
the six fOTOial experiments (CD lU-19) cataloged below as well as studies on
the technique of elimination of white cells from supernatants.
It was demonstrated that 3$ gelatine in saline, conqjared with saline
alone, dramatically hastened the throwing down of red cells and other materials,
so the supernatant was crystal clear while that of the saline suspension of
the same suspension of leukemic cells handled in the same way was cloudy.
However, there were many more white cells in the gelatine supernatant. The
use of gelatine was not continued.
In the first experiment, using 5500 G, two runs of 60 minutes were used.
But this proved unnecessarily long so the runs were cut down to 30 minutes,
then, after still further checking, to 10 minutesj but a third run was added,
so the "supernatant III" means two recentrifugations of the original superna
tant. After the second and third runs the visible sediment consisted of a
small semitransparent disc tightly adherent to the tube.
List of experiments herein reported.
CD lU - Successive supernatants from heated cells (U^°/li4 min,).
CD 15 - ibupernatants after rotation in 37° bath for l/2, 2, k hours,
Leukemic potency of cells after rotation for 6 hours in 37°.
CD l6 - Supernatant III after 37V30 min, in 2h and 1^8 hrs, challenged by
dilution in U8 hrs, by dilution Supernatant IV (from resuspended
sediment II rotated 37°/60 min,) rotated 37°A hrs, and held 2^/h hrs,
CD 17 - Primary supernatant III after rotation in 37°/30 min. injected at
once in comparison with same supernatant rotated 37°A hrs, and held at 2°A
hrs,
CD 18 - Supernatant III after rotation in 37°/30 challenged in 1 hr.,
2 days and 6 days.
CD 19 - Supernatant III from untreated standard suspension of I5, com
pared with supernatant IV after rotation in 37V30. Resuspended sediment I
from each of above supernatants after third washing, rotated in 3T^/60 min.
and each supernatant IV tested <,
EXPERB-IENTS
CD lit.
Can protective effect be obtained from supernatants from line I\y cells
heated (l;6°/lH min«) after removal of primary supernatants? The protection
that appeared in the supernatant of heated cells in CD 10 and 11 (9/20 sur
vived) left a question whether the protective action depended upon something
contributed by the heated cells, or was originally present. So in this experi
ment, after the standard suspension of I^- was rotated 30 min. in ice bath, the
recentrifuged supernatant was tested. The resuspended cells were heated
(ii6°/li4- min.) and after rotating 60 min« in ice, the supernatant II removed
and tested; again the heated cells were resuspended, rotated, and the super
natant II tested; shaking and centrifuging was again repeated, but this super
natant was discarded. For the fourth time the heated cells were resuspended,
shaken, centrifuged and the supernatant II this time tested. None of the mice
given any of the supernatants survived; not even after the primary supernatant.
However, part of the heated cells after their first centrifugation were in
jected into mice, and heated cells after their final centrifugation were also
injected into mice. All of the mice receiving heated cells survived the
challenging dose (it"®) given 2 days later. This experiment runs counter to
the idea that the heated cells yield some protective substances when shaken.
That repeated washing did not lessen the capacity of heated cells themselves
to induce 100^ resistance confirms earlier experiments performed in this
laboratory*
CD 15.
Will supernatants from become more protective if rotated in a 37°
bath, instead of in ice? The time in 37° was varied from l/2, 2 and U hrs.
Supernatants II after these three times gave respective survivors U/lO, 2/lO,
l/lO, In each case one of the mice called a sunrivor, when killed in 21 days
showed signs of subcutaneous infiltration known to be associated with resist
ance that is not quite complete. There is no evidence that prolonged rotation
in 37° increases the protective effect of the supernatants—in fact the reverse
is suggested. However, this is not because the leukemic cells are breaking
down, because after rotation for 6 hrs. in 37° the cells were virtually as
potent in producing leukemia as the original standard suspension. This indi
cated a much greater viability of leukemic cells than has been observed pre
viously) but this is the first time that viability vitro has been studied
with shaking. It seems that previous studies merely measured the rate of
oxygen starvation. This long survival when shaken opens the way to a variety
of studies on the metabolites and other physiological activity of leukemic
cells vitro.
CD 16.
Could the proportion of survivors be increased by clrallenging at a differ
ent time or by using a smaller challenging dose? Will protective action sur
vive rotation of supernatant in 37®/U hrs? Ptevious experiments with heated
cells showing that when subjected to U6o for 7 min. strong resistance at 20
days is induced) when subjected to for lit min. virtually no resistance at
20 days but 100^ resistance at 2 days—raised the question of varying the time
of challenging. Preliminary tests indicating that a dose of or even it'^®
killed all mice, encouraged the use of as a more subtile challenge.
The one day challenge proved as good as that at 2 days—it/lO, compared
with 3/10 survivors; but the dose of gave only 2/10 survivors, and the
controls only 3/10.
Still thinking that the protective substance in the supernatant was in
some way originated in the leukemia cells, the available resuspended cells
seemed possible material for a first effort to answer the question of the
stability of this substance as found in supernatants. Accordingly, resus
pended cells were rotated--37°/60 min. and the supernatant II divided into two
lots—one was rotated in 37°/l4 hrs., the other was held at 2° for U hrs. Then
both injected and the mice challenged in 2 days with Since none of the
cold controls survived, the result is uninterpretable. The protective effect
might have disintegrated in cold as well as in 37® or there may have been
almost none of the protective material in the supernatant from the resuspended
cells.
d) 17.
Continuing the questions of the preceding experiment, the stability of
the protective material was tested using the primary supernatant III after
rotation in 37®/30» I'/hen injected at once, 3/lO survived (one of these when
killed in 25 days showed the superficial infiltrations characteristic of
borderline resistance); when rotated in 37°/ii hrs., l/lO survived (as in CD I6);
when held at 2^/k hrs., 2/lO survived. The resuspended cells from the first
centrifugetion after rotation in 37®/30 gave a supernatant III which failed to
protect any of 10 mice.
To answer conclusively these questions about resistance which at best is
so weak that less than half of the mice survive, is almost inpossible. The
variations in the small number of survivors may or may not have the apparent
meaning. However, it will be noted that the evidence of protective material
being produced vitro is very slight and could well depend upon the incom
plete removal of pre-existing protective material by a single centrifugation.
If this were indeed the case, several washings of the cells would eliminate
the occasional survivors that have raised the question.
CD 18.
Varying time of cliallenge - 1 hour, 2 days, 6 days - after treatment
with supernatant III from standard suspension of I^j after rotation in 37° for
30 minutes.
To reduce possible deterioration during the long preparation of the five
lots of standard suspension of I^^ (-U hrs. - 8? ml.), salt was added to the ice
bath in which the material was held as accumulated. The time for each run in
the centrifuge was reduced to 10 minutes at full speed; the times in protocol
include $ minutes for speeding up. Since CD l6 had shown that challenging in
Zh hours seemed to be as effective as in 2 days, to find resistance in this
experiment when the challenging dose was given in an hour after treatment was
not quite so surprising but this does raise a large doubt as to the identity
of the mechanisms responsible for resistance as induced by these supernatants
and by heated cells. This doubt is further increased by the resistance appear
ing when challenge was delayed for six days, whereas cells heated for lii min.
1+6® would yield to very little resistance when challenged at this time.
Supposing these results are repeatable, they represent the most significant
finding that has been obtained under this contract.
CD 19.
Having been started before the results from CD 18 were known, this experi
ment returned to Idie question of the production of protective material by
leukemic cells 3^ vitro, and included, as a matter of routine, a test of
supernatant III from untreated standard suspension as a direct control on the
effect of rotation in 37°,
The cells in the sediment from \intreated and from rotated suspensions
6separately were twice resuspended and these supernatants discarded; again re-
suspended they were rotated in 37® for 80 minutes. The supernatant III from
each of these lots of washed cells wS^ tested by challenging (U"®) in U8
hours, and gave no survivors from either group of 10 mice each. This seems to
add considerable weight to the probability that the protective material in the
original supernatant was there in the beginning and not put there by the cells
during the period of rotation in 37®.
The two parts of this experiment, combined for practical reasons,
suddenly found important theoretical relationship in the unexpected result
that the supernatant III from untreated standard suspension gave U/lO survivors
when challenged (U"®) in 2 days. Obviously there is some protective material
in the leukeraic spleens which in saline suspensions is immediately separable
ly centrifugation from the leukemic cells.
The fact that the supernatant from the rotated material in this experi
ment gave only 2/10 survivors, cannot be considered significant, for the
experiment was performed in two sections and the rotated and untreated material
came from cell suspensions from different lots of spleens. However, in
sanples as large as ten spleens that came from the same litters, the prob-
stility of significant difference in the two original cell suspensions is not
very high and it is entirely possible that if the rotation at 370 ig not
necessary for the demonstration of the protective material, it may prove to be
a disadvantage.
Thus the final quarter of this year opens with new and unexpected horizons.
CD lU. CSH 2199 lb 2093
III/31 - IV/2/1953
Can protective effect be obtained from supernatants from line lb cells heated
after removal of primary supernatant? (Ii6Vl4 min.)
5:25 ~ 6:55 A.m. 2li ml. standard suspension from 12 line lb spleens, shaken
for 30 min. in crushed ice in m.--:ehanical rotator (90 r.p.m.;.
7:I;0 - 8ji;0 A,M. 5500 G/60 min., 12 ml. supernatant P, recentrifuged.
9!10 - 10:10 A.M. 5500 G/60 rain., Supernatant Pp, in 1.0 ral. doses to 8 dd*
(P) 10:25 A.M.
900 — Sediment P - resuspended; 3 ml. to each of 8 heating vials -
2U°/5 min.j h6^/lh min. - to crushed ice.
10:35 - 1105 A.m. Heated material pooled; shaken for 60 min. in crushed ice
as above*
ll:li5 - 12;li5 P.M. 5500 G/60 min,
12:55 - 1j55 P.M. Supernatant A, recentrifuged - 5500 G/60 min.
— 2:10 P.M. Supernatant A2 in 1.0 ml. doses to 10 dd (A).
— 1:30 P.M. Sediment A resuspended (part) in .25 ml« doses to 10 dd (D).
1:10 - 2:10 P.M. Sediment A resuspended (remainder) shaken /60 min,
2:15 - 3sl5 P*M. 5500 G/60 min. supernatant Bn recentrifuged as before
3:30 - U:30 P.M.
— 1^:55 P«M. Supernatant B2 in 1,0 ml. doses to 10 dd (B)
3:U0 - l;:l40 P.M. Sediment B, resuspended; shaken/60 min.
U:U5 - 5:ii5 P.M. 5500 G/60 min. - supernatant discarded,
6:00 - 7:00 P.M. Sediment C, resuspended; shaken/60 min.
7;05 - 8:05 P.M. 5500 G/60 min. - Supernatant D, recentrifuged as before
8:20 - 9:20 P.M.
-- 9:30 P.M. Supernatant D2 in 1.0 ml. doses to 9 dd (C),
— 8:35 P»M. Sediment D, resuspended; in .25 ml. doses to 9 dd (E).
VI/2 10:00 - 10:U8 P,M. Group A-F (incl.) inoculated .2 ml. U"® dilution
standard suspension of line transfer 2093.
CD 111, (cont.)
Time of deaths in l/U days after challenge with
dilution It""® of line Ij,.
Group
p. Primary supernatant
II after shaking/30
min.
A. Supernatant II after|
resuspension and
lt6Vlit
B. Supernatant II from
1st resuspension of
heated cells
C. Supernatant II from
3rd resuspension of
heated cells
j
D, Sediment after U6®/
lit min.
S. Sediment after 3rd
resuspension of
heated cells
ing dose U"®
 9th ' 10th nth 12th 13th Survived
i  ^
t
1
1
!
0/8
i  ^ 3 1; 1 1 O/lO
7 2 1 0/10
I
!
1 1 0/10
1
1
1
i
i
9/9
i
!
1
j
t
1
9/9
t  1
;  i
3 2 2
1
1 l/lO
GDJ^. CSH 2206 Ii, 2096
liiS.ll cells produce leulcemia after 6 hours rotation in 37® (E & F)?
Supernatants after standard I^j rotated in 37° bath for l/2 (A), 2 (B), and
U hours (C),
Rotation by horizontal rotator, UO per rain. Centrifuging 5500 G 60 mine at
full speed.
V21/53
7«20 A.M. Start killing for spleens; 2 ml. saline per gm. spleen.
10:30 A.M. 32,60 ml. standard divided equally in 5 ml. lots between Erlen-
meyer flasks. A and C to 37° bath and rotatorj 135 ml. volume
immersed at an angle.
11:05 A.M. OO min, plus allowance or warming up) Flask A contents by 5 ml.
syringe to tube A1 (55 ml. lusteroid centrifuge tube): to centrifuge:
top speed 11:15 - 12:15.
12:20 P.M, Supernatant from A1 - 11 ml. to tube A2 and recentrifugedj 1 more
ml. supernatant removed and sediment resuspended in 12 ml. saline,
12:30 P.M. Resuspended sediment A1 to flask B to 37® bath and rotated 2 hours.
1:1:0 P.M. Tube A2, after 60 min. centrifuging, withdrew 10 ml. supernatant to
vialj inject 1,0 nil. to 10 mice - group A - last shot 1:50 P.M.
2:30 PJi. Flasks B and C contents removed with 5 ml. syringes to tubes B1 and
C1 (in flask C "white material" stuck around edge of rotation wave)
to centrifuge - top speed 2;50 - 3:50 P.M.
3:55 P.M. Supernatant from B1 to B2; supernatant from C1 to C2 - to
centrifuge.
i::05 P.M. Sediment from tube C1 resuspended to flask D to 37® bath and
rotator. 2h.
5:05 P.M, Tube B2 withdrew 10 ml. supernatant to vial inject 1,0 ml. to
10 mice « B.
Tube 02 withdrew 10 ml. supernatant to vial, 1.0 ml to 10 mice s 0,
5:30 P.M. Last injection of above.
6;05 P.M. Flask D from bathj inject .2 ml. to 10 mice - group E.
.05 ml. to 10 mice - group F,
.  ^ , last shot 6:20,
V23/53
U:10 - U:25 P.M. Inoo. groups A, B, 0 and untreated controls D with .20 ml.
U-o. These groups included one mouse each from ten litters of four.
Groups E and F, for an independent purpose, are entirely unstaggered.
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CD IB, (cont.)
Time of death by l/k days after challenge (I;"®)
9th 10th nth
i
12th Survived
Group
*  * • ... •  • • •  • «
A. Supernatant II after l/2
hr. in 37°
1 2  2 1 it/io
B. Supernatant II after 2 hrs.
in 37° (resuspension after
37°/30)
2  2 2 1 1 2/10
C. Supernatant II after U hrs.
in 37°
2  li 1 2 Vio
D, Controls on challenge (U'®) 1  6 2  1 0/10
E. Sediment - 6 hrs. in 37° -
.20 ml. dose
F, Sediment - 6 hrs. in 37° -
oO,? ml. dose
Days after injection
kth 5th
7  3
9 1
0/10
0/10
11
CD 16, CSH 2213 lb 2099
CSH 221ii Iv 2099
V/12-II1/53
Reduction in time before challenge and reduction in challenging dose after
treatment with supernatant from standard lb suspension rotated 37°/30 min.
liillll protective action survive rotation of supernatant in 37°/h hrs?
8j20 A.M. Began killing donors, 26 spleens yielded 6I4.I15 ml. standard
suspension plus It.10 ml. from preceding routine transfers - all held
in crushed ice as collected, after passing cotton filter.
11:35 - 12:10 P.M. In two flasks rotated (ItO per min.) 37V35 min.
12:30 - 1:00 P.M. To centrifuge tubes a^ and ^2 ' ^^CO 0/30.
1:15 - 1:U5 P.M. Supernatant I to tubes a^ and a^^ - S500 G/30.
2:05 - 2:35 P.M. Supernatant II to tubes a^ and a^ - 5500 G/30.
3:05 - 3:15 P.M. Supernatant III to vial - in 1.0 ml. doses to 30 cAf
(groups A, B, and G).
1-35 - 2:35 P.M. Sediment I from 1st centrifuge run above, resuspended. to
2 flasks, rotated 37°/60 min.
3:00 - 300 P.M. To centrifuge tubes gi and gg - 5500 G/30 min.
3:50 - U:20 P.M. Supernatant I to tubes g^ and gj^ - 5500 G/30 min.
1^:30 - 8:30 P.M. Supernatant II - 1/2 to flask, rotated 37°/^^ hrs.
Supernatant II - l/2 to tube g^ to 2° room - U hrs.
6:1:5 - 5:00 P.M. Rotated supernatant II in 1,0 ml. doses to 10 (G)
Supernatant II from cold room in 1.0 ml. doses to 10 dV (H)
V/13/53
3:10 - 3:20 P.M. Challenged (U"®) group A and controls D,
v/ll:/53
2:15 - 2:30 P.M. Challenged (U"®) groups B, G. H, and controls E.
2:35 ~ 2:1:5 P.M. Challenged (1:"^) group C and controls F.
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CD 16, (cont.)
Time before death in l/h days after challenge
A. Supernatant III
after 37°/30
Challenged in 2l
- h
D, Controls for A
B. As A, but challenged
M Jift Vive - h"*©in UB hrs. U"
E, Controls for B
C, As A,but challenged
in ii8 hrs.
F, Controls in
for C
G. Supernatant II from
resuspended sediment
I, rotated 37°/^>
rotated 37VU hrs.
challenge it-8 -
U8 hrs.
H. Supernatant II as
for G but held U
hrs. at 2°
E. Controls for G and
H (see above)
9th 10th nth 12th 13th Survived
2  1 1 1 1 U/10
135 1 0/10
1 2  1 1 2 3/10
2 7 1 0/10
1 2  2 1 2 2/10
k 2 1 3/10
3 i; 1 1 1/10
5 3 2
j
0/10
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ID 17. CSH 2219 Ih 2101
V/26-28/53
Does rotation 37®/U hrs. inactivate efrectiveness of priciary supernatant after
37°/30 min. stardard
Do cells produce X-substance in 37°/307
Groups:
A. 1,0 ml. supernatant III after rotation in 37°/30 min, injected at once,
B. 1.0 ml, " " " rotated 37®A hrs,
C. 1,0 ml, " " " held 0° It hrs,
D. 1,0 ml. supernatant III from resuspended sediment I rotated 37V30 min,
E. Controls on challenge 1|""° in li8 hrs.
9s00 A.M. - 12;li0 P.M. Preparation of 71*90 ml, standard suspension from 31
spleens from CSH 221h 1^ 2100 •» in ice bath during preparation,
12AO P.M. 35*8 ml. standard suspension in each of two flasks in 37® bath
rotated 35 min,
IsiiO - 2:10 P.M. 35 ml. in each of two centrifuge tubes 5500 G/30 rain.
2:35 - 3:05 P.M. Supernatant I, 22 ml, per tube 5500 G/30 ndn,
3:20 - 3:35 P.M, Supernatant II, 18 ml, per tube 5500 G/l5 min,
14:00 P.M, Supernatant III inject lOc^cT (A)
3:55 Supernatant III 10+ ml, to flask rotated 37®/l4 hrsj inject 10 <^cr(B)
Supernatant III 10+ ml. to 0® room h hrsj inject 10 cfcT (C)
3:00 - 3:30 P.M, Sediment I, resuspended to original volume rotated 37®/$0 min.
3:ii5 - 14:15 P,M. 5500 G/30 min.
lt:30 - 5:00 P.M. Supernatant I 5500 G/30
5:10 - 5:25 P.M. Supernatant II 5500 G/l5
5:1:0 P.M, Supernatant III inject 1,0 ml, IQd'cf (D)
V/28
1:*3D • 1:«55 P.M. Challenge A, B, C, D, and E controls I4 50 mice •• one
suspension of I4-0 (12 ml.) mixed with 5 ml. syringe.
lU
CD 17. (cont.)
Time of death in l/h days after challenge in 2 days
A. Supernatant III
after 37O/30 min.
B. Same supernatant III
rotated 37°A hrs.
0, Same supernatant III
0° room U hrs.
D. Supernatant III from
sediment I after
37°/30 min.
E. Controls in U"®
9th 10th 11th 12th Delays Survived
•  • • •  • • •  • • «  • • 25 d
18 d
1 2  1 1 1 1 3/10
5  2 2 1/10
3  3 1  1 2/10
1 1 h  h 0/10
h  5 1 O/lO
1:^
CD 18.
CSH 2222 2103
CSH 222U Iv 2103
CSH 2225 lb 2103
CSH 2226 lb 210U
Varying time of challenge after treatment with supernatant III from standard
suspension I^, rotated 37°/50 min.
Standard suspension collected in ice-salt bath: centrifuge runs (5500 G) cut
down to 10 min. plus 5 min. for speeding up.
Vl/9/53
6:30 A.M. Began killing donors of spleens: 31 spleens yielded 8? ml,
standard suspension.
10:li0 - 11:30 A.M. Rotated (50 per min.) in 2 flasks in 37° bath.
11:1:7 - 12:08 P.M. Centrifuged in 2 lusteroid tubes 5500 G/iO (+5) min.
12:17 - 12:32 P.M. Supernatant I - 5500 G/lO (+5) min.
12:I;1 - 12:U6 P.M. Supernatant II - 5500 G/lO (+5) min.
1:0? - 1:30 P.M. Supernatant III - in 1.0 ml. doses to UO cAf - groups A, B,
C) D.
2:00 - 2:08 P.M. Challenged (0.2 ml. doses 1.-0) group A (l hour).
Vl/10/53
1:35 - 1:39 P.M. Challenged (1^"®) group B (21: hoxirs).
Vl/11/53
1:15 - 1:20 P.M. Challenged (U"®) group C (U8 hours).
V3yi5/53
U:20 - U:25 P.M, Challenged (1:"®) group D (6 days).
CD 18. (cont.)
16
Time before challenge
A. 1 hr. CSH 2222
A - Controls
B. 2h hrs. CSH 222U
B - Controls -
technical errors
no leukemia
C. U8 hrs. CSH 2225
0 - Controls
D. 6 days
CSH 2226
D. Controls
7 d
2
Time of death in l/h days - after challenge (1;"®)
9th 10th
1  2
nth
1 2
3
5 2
1  8
12th
2 1
Survived
5/10
0/10
5/10
1/10 z recovery-"
had large spleen
6/10
oAo
17
CD 19» CSH 229 lb 210lt
Vl/16-18/53
Can aiy protective effect be obtained from:
1. Supernatant III, from untreated standard suspension of lb compared
with rotation 37°/30 min?
2. Supernatant III from washed (x3) cells resuspended for Uth time and
then rotated 37°/80 min?
In order to reduce the excessive time between killing first donor and first
injection of mice, this e^eriment was performed in 2 sections. In each
section 10 spleens were minced together and when suspended in saline at once
rotated without chilling. The donors of the two lots of spleens came from
the same litters in nearly equal numbers.
Section I.
8:30 A.M. Began killing donors; 10 spleens yielded 18.25 ml. standard
suspension.
900 - 10:00 A.M. Rotated 37°/30 min. - to centrifuge tube 1.
10:05 - 10:15 A.M. 5500 O/lO +5 min.
10:26 - 10:Ul A.M. Supernatant I - to tube 2 \ tcrxr, r/io r-
Sediment I, resuspended tube 1 J
10:55 - 11:10 A.M. Supernatant II from tube 2 to tube 3\ ^
Sediment II resuspended (2) tube 1 j 0/10 +5 min.
11:30 A.M. Supernatant III from tube 3 ~ to vial. In 1.0 ml. doses to
lOSd' (A)
11:20 - 12;i:0 P.M. Sediment III from tube 1, resuspended, to flask, rotated
37°/80 min.
12:U5 - 1:00 P.M. To tube h - 5500 O/lO +5 min.
Isl5 - 1:30 P.M. Supernatant I to tube 5 - 5500 O/lO +5.
1:U5 - 2:00 P.M. Supernatant II to tube 6 - 5500 G/lO +5.
2:25 P.M. Supernatant III to vial, held in 0° room 25 min., then in 1,0 ml.
doses to 10 cAT (B)
Section II.
11:1:5 A.m. Began killing donors: 10 spleens yielded 23 ml. standard
suspension.
12:1:5 - 1:00 P.M. Directly to centrifuge tube a - 5500 O/lO +5 min.,
with tube U.
18
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CD 19. (cont.)
I:l5 - ls30 P.H, Supernatant I to tube b
Sediment I, tube a resuspended} 5500 G/10 +5 with tube 5
l:U5 - 2sOO P.M. Supernatant II to tube c J 5
Sediment II, tube a resuspended.
2:10 - 3:30 P.M. Sediment III, tube a, resuspended, to flask, rotated
370/80 min.
2:33 P.M. Supernatant III, from tube c, to vial, in 1.0 ml. doses to 10 d«r(C)
3:35 - 3:50 P.M. Rotated sediment HI to tube d - 5500 G/lO +5 min.
3:37 - U:12 P.M. Supernatant I from tube d to tube e - 5500 G/lO +5 min.
l:;20 - U;35 P*M. Supernatant II from tube e to tube f - 5500 G/lO +5 min,
U:li5 P.M. Supernatant III from tube f - in 1.0 ml. doses to 10 d'cf.
Vl/18/53
3:00 - 3:19 P.M. Challenged A, B, C, D and E - 0.2 ml. dose - dilution U"®
of standard suspension of Iij.
Time before death in l/h days.
9th 10th nth Survived
Supernatant III fiom;- •  • • •  • • •  • •
Section I
Ai Rotated 37°/30 1 1  2 2 1 1 2/10
B. Tfliashed cells from 1 12 2 2 11 ' 0/10
above rotated 37°/80
Section II
C. Untreated standard h  1 1 lyio
suspension
D. Trjashed cells from 1  6 2 1 delayed O/lO
above rotated 37°/80 18 d.
E. Controls in challenge 1 2  2 2 3 0/10
dose U"®
1
mM
